[State Food and Drug Administration: Encourage foreign investment to introduce original research drugs and high-end medical equipment into domestic production] On September 20, Yang Sheng, deputy director of the State Food and Drug Administration, stated at a press conference of the State Council Information Office that it would support the large-scale, intensive, and high-end development of the pharmaceutical industry. Pharmaceutical companies are encouraged to build smart and green factories, and will continue to support the development of the pharmaceutical industry in the Beijing-Tianjin-Hebei region, the Yangtze River Delta, the Guangdong-Hong Kong-Macao Greater Bay Area, the Chengdu-Chongqing economic circle and other regions, and strive to cultivate 3-5 internationally competitive biopharmaceutical industry innovation clusters. We will support the expansion of opening-up and cooperation in the pharmaceutical field, encourage foreign investment to introduce original research drugs and high-end medical equipment for domestic production, and also encourage Chinese companies to go global and develop so that China's pharmaceuticals and equipment can benefit the world.